drugset / Trial / NCT02229539

Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy

NCT02229539

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test whether a mouthwash made with a drug called doxepin can reduce the pain caused by mouth sores resulting from radiation therapy. A number of mouth rinse preparations exist for patients with treatment-related oral mucositis pain such as the DLA rinse, an over-the-counter medication. This study will evaluate the effects of doxepin compared to DLA (diphenhydramine, lidocaine and antacids) and placebo.Doxepin is approved by the Food and Drug Administration (FDA) for the treatment of depression, anxiety, long-term pain management, as well as management of rash.

Timeline

Start
2014-11-18
Primary completion
2016-05-23
Completion
2019-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diphenhydramine Unknown Oral
Subject Doxepin Unknown 25 mg Oral
Comparator Lidocaine Other / unclassified Oral

Indications